HomeKAPA • NYSEAMERICAN
add
Kairos Pharma Ltd
Previous close
$1.03
Day range
$0.91 - $1.13
Year range
$0.85 - $4.00
Market cap
12.46M USD
Avg Volume
104.98K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 383.00K | 33.45% |
Net income | -1.05M | -235.58% |
Net profit margin | — | — |
Earnings per share | -0.10 | — |
EBITDA | -343.00K | -38.87% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.22M | 3,149.49% |
Total assets | 5.00M | 427.85% |
Total liabilities | 1.67M | -40.73% |
Total equity | 3.33M | — |
Shares outstanding | 12.85M | — |
Price to book | 3.96 | — |
Return on assets | -31.74% | — |
Return on capital | -119.46% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.05M | -235.58% |
Cash from operations | -2.02M | -2,319.78% |
Cash from investing | — | — |
Cash from financing | 5.22M | 2,428.57% |
Net change in cash | 3.20M | 2,503.01% |
Free cash flow | -3.34M | -2,559.10% |
About
Founded
2013
Headquarters
Website
